L'Oréal takes majority stake in Innovist, valuing Bare Anatomy parent at up to $450M
L'Oréal has signed to acquire a majority stake in Innovist, parent of Bare Anatomy and Chemist at Play, at a reported $350-450M (Rs 3,240-4,170 crore) valuation. The deal, closing in coming months, would mark India's largest beauty D2C acquisition, dwarfing HUL-Minimalist (Rs 2,955 cr) and HUL-Oziva (Rs 824 cr).
What happened
L'Oréal signed an agreement to acquire majority stake in Innovist, parent of Bare Anatomy and Chemist at Play, reportedly valuing the D2C personal care firm at
Key facts
- $350M-$450M valuation
- Rs 3,240-4,170 crore
- Rs 824 crore Oziva deal
- Rs 375 crore Cosmix
- Rs 2,955 crore Minimalist
Why this matters
Global strategics are now actively bidding for Indian beauty platforms, so move fast on diligence for remaining scaled D2C targets before HUL, Unilever, and Estée Lauder close the window on competitive auctions.
Also reported by
- Entrackr — Same time